8-K//Current report
POINT Biopharma Global Inc. 8-K
Accession 0001811764-23-000031
CIK 0001811764operating
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 4:05 PM ET
Size
270.6 KB
Accession
0001811764-23-000031
Documents
- 8-Kpnt-20230728.htmPrimary
8-K
- EX-16.1pointbiopharmaglobalincl.htm
EX-16.1
- EX-101.SCHpnt-20230728.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABpnt-20230728_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREpnt-20230728_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICpointbiopharmaglobalincl001.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLpnt-20230728_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001811764-23-000031-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeoperating
Related Parties
1- filerCIK 0001811764
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 4:05 PM ET
- Size
- 270.6 KB